MyFinsight
Home
Blog
About
Contact
Download
Download image
Antiviral And Anti
Infective
$34,657K
Cardiology
$60,659K
Central Nervous System
$64,041K
Other
$92,044K
Metabolic
$198,914K
Oncology
$183,196K
Interest income
(expense), net
$3,722K
Revenue, net (includes
53.2 million, 50.0...
$633,510K
Total other income
(expense), net
$3,564K
Income from operations
$153,269K
Miscellaneous (expense)
income, net
-$158K
Total operating
expenses
$519,987K
Income before income
taxes
$156,833K
Amortization
$237K
Depreciation
$6,794K
Selling, general and
administrative
$51,407K
Direct operating costs
$441,677K
Net income
$135,133K
Income tax provision
$21,700K
Reimbursable Out Of Pocket
Costs
$261,694K
Direct Costs
$179,984K
Back
Back
Income Statement
source: myfinsight.com
Medpace Holdings, Inc. (MEDP)
Medpace Holdings, Inc. (MEDP)